Frontiers in oncology.

Department of Oncology, Infermi’s Hospital, Azienda Unità Sanitaria Locale (AUSL) della Romagna, Faenza, Italy; Around 8–12% of patients with advanced colon rectal cancer (CRC) present with BRAF alterations, in particular V600E mutation, which is associated with right-side, poorly differentiated and mucinous type tumors.

Frontiers in oncology. Things To Know About Frontiers in oncology.

Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize... Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ... Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring …Frontiers Books allows users to browse, free of charge, through the pages of Frontiers e-books and e-magazines or download the entire pdf. You may also purchase hardcopy issues as well as other academic literature. ... Keywords: head and neck cancer,­oncology,­methods,­CancerBiological Functions and Therapeutic Potential of SRY related high mobility group box 5 (SOX5) in human cancer. Xue juan Di. Wanfang Xiang. Ming-qin Cai. Xiaoyun Lv. Frontiers in Oncology. doi 10.3389/fonc.2024.1332148. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.

Mohamed Rahouma. Massimo Baudo. Magdy M. El-Sayed Ahmed. Frontiers in Oncology. doi 10.3389/fonc.2023.1271452. 776 views. Part of a forward-thinking journal, this section covers the entire emerging interface between cardiovascular medicine and oncology.Scope. This section aims to publish significant clinical and basic research findings on all aspects related to hematologic malignancies, including the areas of acute and chronic leukemias, lymphomas and Hodgkin’s disease, plasma cell disorders, and stem cell transplantation. Our ultimate goal is to accelerate the communication in the field ...In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 …

See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.

1 Introduction. The human epidermal growth factor receptor protein tyrosine kinase family, including EGFR and HER2, has emerged as an important therapeutic target for non-small cell lung cancer, breast cancer, and gastroesophageal cancer (1, 2).In NSCLC, EGFR exon 20 insertions mutations account for 1.5-2.5% of all NSCLC, 6% of …Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...Browse the latest research articles published in Frontiers in Oncology, a leading open access journal in the field of cancer. Find original research, reviews, …Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ).

Social security office evansville

本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况,以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 …

LetPub整理了最新的Frontiers in Oncology 期刊投稿经验, 期刊官方投稿网址,影响因子,审稿周期/时间,研究方向,SCI期刊分区,中国作者发表的文章等信息, ...penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.4 days ago · Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ... Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...Quan Yuan. Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.

1 Introduction. RMS is the most common soft tissue sarcoma in children, accounting for about half of all soft tissue tumors, which are usually localized in the extremities, trunk, head, and neck (1, 2).It is rarely observed in adults and only accounts for 3% of adult soft tissue sarcomas, which has a significantly worse prognosis compared to …Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast ...Pediatric Oncology. sergi aranda. National Center for Genomic Analysis, Center for Genomic Regulation (CRG) Barcelona, Spain. Associate Editor. Pediatric Oncology. nicoleta arva. Feinberg School of Medicine, Northwestern University. …The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ...Jun 27, 2021 · In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 incubator. Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.

Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center.

Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.Frontiers in Oncology is composed of the following specialties: Cancer Endocrinology . Cancer Epidemiology and Prevention . Cancer Genetics . Cancer Imaging and Diagnosis …markus brunner. Medical University of Vienna. Vienna, Austria. Associate Editor. Head and Neck Cancer. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Submissions that are surgical in nature are not in scope for this section and should be submitted to the Surgical Oncology Section of Frontiers in Oncology. Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and …

Ultra stores

Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.

Some hardships faced by frontier farmers were a lack of rainfall and dense earth that was difficult to plow, owing to the tough grasses of the Great Plains.Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups.We conducted a rapid bibliometric evaluation of TDM in oncology to capture a snapshot of research in this area over time and explore topics that reflect development in the field. Reports with the composite, indexed term ‘therapeutic drug monitoring’ in the title and abstract were extracted from MEDLINE (inception to August 2021).1 Introduction. Immune checkpoint molecules play a crucial role in the immune regulation of malignant tumors, and their biological significance is essential for the diagnosis, prognosis, and treatment of tumors ().Checkpoints are located on various immune cells, including T lymphocytes, or on tumor cells, and they function like switch …Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况,以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 …Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...brian d adams. Brain Institute of America. New Haven, United States. Associate Editor. Cancer Molecular Targets and Therapeutics.

Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize...bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.116. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat oncology biology physics (1995) 31(5):1341–6. doi: 10.1016/0360-3016(95)00060-C. CrossRef Full Text | Google Scholar1 Introduction. RMS is the most common soft tissue sarcoma in children, accounting for about half of all soft tissue tumors, which are usually localized in the extremities, trunk, head, and neck (1, 2).It is rarely observed in adults and only accounts for 3% of adult soft tissue sarcomas, which has a significantly worse prognosis compared to …Instagram:https://instagram. socal edision The Urologic Oncology section of Frontiers in Urology publishes high-quality fundamental clinical and translational research, as well as, in-depth reviews across the field of urologic oncology. This section covers the areas including, but not limited to: - Renal cell carcinoma and other renal pathology - Prostate cancer - Bladder cancer what is character.ai Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ... el pronostico Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ...They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field. maps with latitude and longitude Learn how to prepare and submit your manuscript to Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the articl… shadow ban test How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research.Radiotherapy for Esophageal Cancer: Molecular Mechanism and Novel Targets to Improve Radiosensitivity. Xiaodong Li. Yanqing Liu. Adam Yongxin Ye. Xiao Zheng. 7,350 views. 6 articles. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and ... colombus crew SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.If you’re looking for an affordable airline option, Frontier Airlines might be the perfect choice. With their low fares and various routes, it’s no wonder that many travelers choos... where is st lucia in the caribbean Preprint repository name [Preprint] (2008). Available at: https://persistent-url (Accessed March 15, 2018). Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Targeting Tumor Microenvironment and Metabolic Reprogramming in Triple-negative Breast Cancer. Weipeng Zhao. Lili Yang. Shengyu Yang. 11,564 views. 5 articles. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells.The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ... parkmobile log in In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 incubator. st louis kansas city May 10, 2024 · This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment. westlake financial pay bill Frontiers Books allows users to browse, free of charge, through the pages of Frontiers e-books and e-magazines or download the entire pdf. You may also purchase hardcopy issues as well as other academic literature. ... Keywords: head and neck cancer,­oncology,­methods,­CancerFrontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order. my q Since then, the development of ICIs represents a paradigm shift in oncology therapy and prompted us to further study the role of ICIs in treatment of patients with BM. The Checkmate 204 trial of dual ICI therapy showed a dramatic intracranial response rate of 57% of BM from melanoma ( 10 ), as did the randomized phase II ABC …Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ).3 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.